Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Aeterna Zentaris Announces Proposed Public Offering of Common Shares and Warrants
-
Notable Analyst Rating Changes 3/5: (NRF) (RGR) (GDOT) Upgraded; (GDP) (MCD) (INXN) Downgraded
-
UPDATE: Canaccord Genuity Downgrades InterXion Holding (INXN) to Hold
-
Canaccord Genuity Downgrades Oasis Petroleum (OAS) to Hold
-
Ambarella (AMBA) PT, Estimates Lifted at Canaccord Genuity on 'Very Strong' Q4
-
Dick's Sporting Goods (DKS) PT Raised to $59 at Canaccord Genuity; 'Hold' Maintained
-
ZELTIQ Aesthetics (ZLTQ) PT Lifted to $39 at Canaccord Genuity Post Q4
-
Canaccord Genuity Upgrades Laboratory Corporation of America (LH) to Buy
-
Canaccord Genuity Upgrades Quest Diagnostics (DGX) to Buy
-
Streetinsider.com's Hot Lunchtime Reads 3/2: (PTN) (TSLA) (SD) (AAPL)
-
UPDATE: Canaccord Genuity Starts Palatin Technologies (PTN) at Buy
-
K2M Group Holdings, Inc. to Present at Upcoming Investor Conferences
-
Kornit Digital (KRNT) Files $115M IPO
-
Avago Technologies (AVGO) PT Raised to $145 at Canaccord Genuity
-
UPDATE: Canaccord Genuity Starts Earthstone Energy (ESTE) at Buy
-
Comcast (CMCSA) PT Raised to $70 at Canaccord Genuity
-
Canaccord Genuity Downgrades HSBC Holdings (HSBC) to Hold
-
Canaccord Genuity Starts Avinger (AVGR) at Buy
-
ARM Holdings (ARMH) PT Raised to $60 at Canaccord Genuity
-
Canaccord Genuity Starts Entellus Medical (ENTL) at Buy
-
Sovaldi Pricing Controversy Offers Little Read-Through for PSCK9s - Canaccord (REGN) (GILD) (AMGN)
-
Notable Analyst Rating Changes 2/20: (MRVL) (DSW) (KN) Upgraded; (FUEL) (HLSS) (REGN) Downgraded
-
UPDATE: Canaccord Genuity Downgrades Northern Oil and Gas (NOG) to Hold
-
UPDATE: Canaccord Genuity Downgrades Approach Resources (AREX) to Hold
-
UPDATE: Canaccord Genuity Upgrades DSW Inc. (DSW) to Buy
-
Novatel Wireless (MIFI) PT Lifted to $5 at Canaccord Genuity
-
Astronics (ATRO) PT Raised to $77 at Canaccord Genuity
-
Integra LifeSciences to Participate in the Raymond James Institutional Investors Conference, Barclays Global Healthcare Conference and the Canaccord Genuity Musculoskeletal Conference in March
-
Some FY15 Targets for Stratasys (SSYS) Appear Conservative; Canaccord Affirms at 'Buy'
-
UPDATE: Canaccord Genuity Downgrades Castlight Health Inc. (CSLT) to Hold
-
UPDATE: Canaccord Genuity Upgrades Hologic (HOLX) to Buy; Survey 'Overwhelmingly Positive'
-
SolarCity (SCTY) PT Raised to $67 at Canaccord Genuity
-
Actavis (ACT) PT Lifted to $352 at Canaccord Genuity
-
Inotek Pharma (ITEK) IPO Opens Modestly Higher
-
UPDATE: Canaccord Genuity Starts Celgene (CELG) at Buy
-
UPDATE: Canaccord Genuity Downgrades Insulet Corporation (PODD) to Hold
-
Inotek Pharma (ITEK) Prices 6.67M Common IPO at $6/Share; Announces $20M Conv. Senior Notes Offering
-
Notable Analyst Rating Changes 2/17: (SRPT) (MU) (CCG) Upgraded; (IMAX) (CVC) (JWN) Downgraded
-
UPDATE: Canaccord Genuity Downgrades IMAX Corporation (IMAX) to Hold
-
Ultragenyx Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Canaccord Genuity Starts Box, Inc. (BOX) at Hold
-
Stryker (SYK) Can Get a Smith & Nephew (SNN) Deal Done at $45/Share - Canaccord Genuity
-
Cognex (CGNX) PT Lifted to $55 at Canaccord Genuity on 'Solid' Q4
-
Zynga (ZNGA) PT Cut to $2.50 at Canaccord Genuity
-
ReWalk Robotics (RWLK) PT Cut at $17 at Canaccord Genuity
-
RTI Biologics (RTIX) PT Lifted to $7 at Canaccord Genuity
-
Digital Realty Trust (DLR) PT Bumped to $72 at Canaccord Genuity
-
Klox Technologies (KLOX) Files for $75M IPO
-
Notable Analyst Rating Changes 2/12: (ALLY) (CPA) (MOS) Upgraded; (TSLA) (FTI) (ZU) Downgraded
-
Transition Therapeutics (TTHI) Prices 3.08M Share Offering at $6.50/Sh

